Minoxidil and Application site hypersensitivity - a phase IV clinical study of FDA data

Summary:

Application site hypersensitivity is reported as a side effect among people who take Minoxidil (minoxidil), especially for people who are male, 30-39 old, have been taking the drug for < 1 month also take Escitalopram, and have Dementia alzheimer's type.

The phase IV clinical study analyzes which people have Application site hypersensitivity when taking Minoxidil. It is created by eHealthMe based on reports of 29,340 people who have side effects when taking Minoxidil from the FDA, and is updated regularly.

What is Minoxidil?

Minoxidil has active ingredients of minoxidil. It is often used in hair loss. eHealthMe is studying from 29,925 Minoxidil users. Check the latest studies of Minoxidil.

What is Application site hypersensitivity?

Application site hypersensitivity is found to be associated with 105 drugs and 282 conditions by eHealthMe. Check the latest studies of Application site hypersensitivity.

On Jul, 14, 2026

29,340 people reported to have side effects when taking Minoxidil.
Among them, 20 people (0.07%) have Application site hypersensitivity.

Could Minoxidil cause Application site hypersensitivity?

Among these 20 people:

How long have people been on Minoxidil when they have Application site hypersensitivity? *

What is the gender of people who have Application site hypersensitivity when taking Minoxidil? *

female: 21.05 %
male: 78.95 %

What is the age of people who have Application site hypersensitivity when taking Minoxidil? *

What are other drugs people take besides Minoxidil? *

Promethazine: 1 person, 5.00%
Lovastatin: 1 person, 5.00%
Losartan: 1 person, 5.00%
Escitalopram: 1 person, 5.00%

What are other side effects people have besides Application site hypersensitivity? *

Application Site Pruritus (application site severe itching of the skin): 3 people, 15.00%
Application Site Irritation: 2 people, 10.00%
Application Site Erythema (redness of the skin at application site): 2 people, 10.00%
Urticaria (rash of round, red welts on the skin that itch intensely): 1 person, 5.00%
Psoriasis (immune-mediated disease that affects the skin): 1 person, 5.00%
Ocular Discomfort (a generic expression when there is lack of ease in/about the eyes): 1 person, 5.00%
Headache (pain in head): 1 person, 5.00%
Hair Texture Abnormal: 1 person, 5.00%
Growth Of Eyelashes: 1 person, 5.00%
Dry Throat: 1 person, 5.00%

What are the existing conditions these people have? *

Hyperlipidaemia (presence of excess lipids in the blood): 1 person, 5.00%
Dementia Alzheimer's Type (loss of mental ability with alzheimer's symptom): 1 person, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Minoxidil and have Application site hypersensitivity?

- Check whether Application site hypersensitivity is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Minoxidil:

Minoxidil (29,925 reports)

Browse all side effects of Minoxidil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Application site hypersensitivity:

Application site hypersensitivity (105 drugs)

Browse all the conditions that are associated with Application site hypersensitivity:

Application site hypersensitivity (282 conditions)

Related publications that referenced our studies

Dubrey SW, VanGriethuysen J, Edwards CM, "A hairy fall: syncope resulting from topical application of minoxidil", BMJ case reports, 2015 Sep .
Dubrey SW, VanGriethuysen J, Edwards CM, "A hairy fall: syncope resulting from topical application of minoxidil", BMJ case reports, 2015 Sep .

How the study uses the data?

The study uses data from the FDA. It is based on minoxidil (the active ingredients of Minoxidil) and Minoxidil (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.